S&P MidCap 400 Pure Growth Fund GMED Holdings History
S&P MidCap 400 Pure Growth Fund's Globus Medical Inc Holding Summary
As of 2025-03-31, RYDEX SERIES FUNDS held 6,654.00 shares of Globus Medical Inc(GMED), totaling $487,070.00. This investment constitutes 1.94% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding Globus Medical Inc(GMED) stock.
The initial trade took place in 2019Q3. And since then S&P MidCap 400 Pure Growth Fund has made 1 purchases of GMED, at an average price of $56.16, for a total of 27,664.00 shares. In addition, there have been 2 sales at an average price of $55.52 for 21,010.00 shares. Based on historical transaction data and GMED's current price of $56.34, S&P MidCap 400 Pure Growth Fund's estimated gain on his GMED holdings is $-12,280.74, reflecting a -0.79% gain to date.
S&P MidCap 400 Pure Growth Fund GMED ($56.34) Holding Chart
S&P MidCap 400 Pure Growth Fund GMED ($56.34) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1